Replies to post #247044 on Biotech Values

[Biowatch]

Drug Shortages Stem_From_Quality_Problems_in India

https://www.wsj.com/articles/drug-shortages-stem-from-quality-problems-in-indian-factories-20accc00

https://www.bloomberg.com/news/articles/2023-06-15/quality-issues-grow-at-generic-drugmaker-causing-chemo-scarcity

US regulators have discovered yet another plant rife with problems run by Intas Pharmaceuticals Ltd., a generic drugmaker whose quality issues have caused one of the worst shortages of cancer medications in decades.

Intas, a privately held company, makes more than 100 generic drugs approved in the US and has three production facilities in Ahmedabad, India, according to Food and Drug Administration data. One of those facilities shut down after the FDA found shredded documents about drug quality, indicating serious lapses at the plant and raising doubts about the safety and efficacy of its drugs.

———-
You can look up particular drug shortages by searching on “drug shortage” or here:
https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages

Click on “Drug Shortage Database”